TP53AIP1
p53-regulated apoptosis-inducing protein 1
Also known as: p53AIP1, TPIP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HCN2
- Gene
- TP53AIP1
- Ensembl
- ENSG00000120471
- Chromosome
- 11
- Canonical length
- 124 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene is specifically expressed in the thymus, and encodes a protein that is localized to the mitochondrion. The expression of this gene is inducible by p53, and it is thought to play an important role in mediating p53-dependent apoptosis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
124 residues, UniProt reviewed canonical sequence.
>Q9HCN2|TP53AIP1
1 MGSSSEASFR SAQASCSGAR RQGLGRGDQN LSVMPPNGRA QTHTPGWVSD PLVLGAQVHG
61 GCRGIEALSV SSGSWSSATV WILTGLGLGL SRPFLPGATV LRDRPLGSAF ELSYDQKKAP
121 LRLQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TP53AIP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.75
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- thymus: 28 nTPM
- esophagus: 25 nTPM
- skin: 19 nTPM
- cervix: 15 nTPM
- vagina: 14 nTPM
- salivary gland: 3.8 nTPM
Single-cell type
- esophageal basal cells: 158 nCPM
- epididymal efferent duct ciliated cells: 114 nCPM
- breast myoepithelial cells: 77 nCPM
- basal keratinocytes: 56 nCPM
- endometrial ciliated cells: 39 nCPM
- epididymal basal cells: 30 nCPM
Immune cell
- basophil: 0.2 nTPM
- neutrophil: 0.2 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebellum: 3.9 nTPM
- cerebral cortex: 3.7 nTPM
- hypothalamus: 3.7 nTPM
- medulla oblongata: 3.6 nTPM
- midbrain: 3.6 nTPM
- pons: 3.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.95
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.04
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- p53-regulated apoptosis-inducing protein 1
- p53-regulated apoptosis-inducing protein 1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TP53AIP1 as an antibody target. Whether an autoantibody or antibody against TP53AIP1 could matter depends on whether native TP53AIP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TP53AIP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TP53AIP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...